The neuroimmune hypothesis in Parkinson's disease

被引:0
作者
Kuhn, W [1 ]
Muller, T [1 ]
Nastos, I [1 ]
Poehlau, D [1 ]
机构
[1] RUHR UNIV BOCHUM,ST JOSEF HOSP,DEPT NEUROL,D-44791 BOCHUM,GERMANY
关键词
Parkinson's disease; immune mechanisms; cytokines;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The role of immune mechanisms in the pathogenesis of Parkinson's disease is still a matter of controversy. Immunological abnormalities have been reported in various brain areas and in peripheral immune parameters. Beside antigen specific findings which might indicate an autoimmune process directed against dopaminergic neurons, non-antigen specific abnormalities have been found, which could be caused either by a disease specific process and/or by immunological properties of various antiparkinsonian drugs, e.g. bromocriptine. Immune reactions may imitate or maintain the degenerative process. In this case possible neuroprotective strategies interfering with immune functions could be developed. Further investigations are necessary to elucidate the impact of immune mechanisms on the degenerative process in Parkinson's disease.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 69 条
[1]  
ABB J, 1984, BLUT, V48, P285
[2]  
ABRAMSKY O, 1978, PERSPECT BIOL MED, V22, P104
[3]   PSYCHONEUROIMMUNOLOGY - INTERACTIONS BETWEEN THE NERVOUS-SYSTEM AND THE IMMUNE-SYSTEM [J].
ADER, R ;
COHEN, N ;
FELTEN, D .
LANCET, 1995, 345 (8942) :99-103
[4]   NIGRAL DAMAGE AND DOPAMINERGIC HYPOFUNCTION IN MESENCEPHALON-IMMUNIZED GUINEA-PIGS [J].
APPEL, SH ;
LE, WD ;
TAJTI, J ;
HAVERKAMP, LJ ;
ENGELHARDT, JI .
ANNALS OF NEUROLOGY, 1992, 32 (04) :494-501
[5]   INDUCTION OF IMMUNE-SYSTEM MEDIATORS IN THE HIPPOCAMPAL-FORMATION IN ALZHEIMERS AND PARKINSONS DISEASES - SELECTIVE EFFECTS ON SPECIFIC INTERLEUKINS AND INTERLEUKIN RECEPTORS [J].
ARAUJO, DM ;
LAPCHAK, PA .
NEUROSCIENCE, 1994, 61 (04) :745-754
[6]   LOCALIZATION OF INTERLEUKIN-2 IMMUNOREACTIVITY AND INTERLEUKIN-2 RECEPTORS IN THE RAT-BRAIN - INTERACTION WITH THE CHOLINERGIC SYSTEM [J].
ARAUJO, DM ;
LAPCHAK, PA ;
COLLIER, B ;
QUIRION, R .
BRAIN RESEARCH, 1989, 498 (02) :257-266
[7]   IMMUNOLOGICAL CHANGES IN THE MPTP-INDUCED PARKINSONS-DISEASE MOUSE MODEL [J].
BIEGANOWSKA, K ;
CZLONKOWSKA, A ;
BIDZINSKI, A ;
MIERZEWSKA, H ;
KORLAK, J .
JOURNAL OF NEUROIMMUNOLOGY, 1993, 42 (01) :33-38
[8]   Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients [J].
BlumDegen, D ;
Muller, T ;
Kuhn, W ;
Gerlach, M ;
Przuntek, H ;
Riederer, P .
NEUROSCIENCE LETTERS, 1995, 202 (1-2) :17-20
[9]   IMMUNOCYTOCHEMICAL ANALYSIS OF TUMOR-NECROSIS-FACTOR AND ITS RECEPTORS IN PARKINSONS-DISEASE [J].
BOKA, G ;
ANGLADE, P ;
WALLACH, D ;
JAVOYAGID, F ;
AGID, Y ;
HIRSCH, EC .
NEUROSCIENCE LETTERS, 1994, 172 (1-2) :151-154
[10]   DIFFERENTIAL EFFECT OF MIXED D1/D2 AND SELECTIVE D2 DOPAMINERGIC ANTAGONISTS ON MOUSE LYMPHOCYTE-T AND LYMPHOCYTE-B PROLIFERATION AND INTERLEUKIN PRODUCTION INVITRO [J].
BOUKHRIS, W ;
KOUASSI, E ;
REVILLARD, JP .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 1988, 10 (04) :501-512